TY - JOUR
T1 - Role of large Ca2+-activated K+ channels in regulation of mesangial contraction by nitroprusside and ANP
AU - Stockand, James D.
AU - Sansom, Steven C.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1996/6
Y1 - 1996/6
N2 - The patch-clamp method, in conjunction with measurements of cell contraction, was employed to investigate activation by guanosine 3',5'- cyclic monophosphate (cGMP) and guanylyl cyclase-stimulating vasodilators of large Ca2+-activated K+ channels (BK(Ca)) in human glomerular mesangial cells (MC). In cell-attached patches, with physiological NaCl bathing solutions, BK(Ca) was activated transiently by nitroprusside [NP; a nitric oxide (NO) donor], atrial natriuretic peptide (ANP), and dibutyryl cGMP (DBcGMP), reaching peak responses between 10 and 60 s and decreasing to near baseline activity within the next 120 s. In the presence of LY-83583, a specific inhibitor of guanylyl cyclase, BK(Ca) was activated on cell by DBcGMP but not by NP or ANP. In all cases, the increase in channel activity coincided with a decrease in channel amplitude, indicating that the membrane potential was approaching equilibrium potential as BK(Ca) was activated. If membrane potential was maintained depolarized with 140 mM KCl in the bathing solution, DBcGMP induced a sustained activation of BK(Ca). In the continued presence of DBcGMP, BK(Ca) was further activated when 100 nM angiotensin II (ANG II) was added to the bathing solution. Experiments were performed to determine the role of BK(Ca) in the regulation by vasorelaxants of mesangial contraction measured as percent maximal and defined by reduction in length induced by replacing 135 mM bath NaCl with KCl. Contraction by ANG II (100 nM = 60.5%) was attenuated by NP (100 μM), ANP (1.0 μM), and DBcGMP (10 μM) in the absence, but not the presence, of iberiotoxin, a specific inhibitor of BK(Ca). These results indicate that guanylyl cyclase-stimulating vasorelaxants counteract ANG II-induced contraction of MC, in part, by repolarizing the membrane through activation of BK(Ca) channels.
AB - The patch-clamp method, in conjunction with measurements of cell contraction, was employed to investigate activation by guanosine 3',5'- cyclic monophosphate (cGMP) and guanylyl cyclase-stimulating vasodilators of large Ca2+-activated K+ channels (BK(Ca)) in human glomerular mesangial cells (MC). In cell-attached patches, with physiological NaCl bathing solutions, BK(Ca) was activated transiently by nitroprusside [NP; a nitric oxide (NO) donor], atrial natriuretic peptide (ANP), and dibutyryl cGMP (DBcGMP), reaching peak responses between 10 and 60 s and decreasing to near baseline activity within the next 120 s. In the presence of LY-83583, a specific inhibitor of guanylyl cyclase, BK(Ca) was activated on cell by DBcGMP but not by NP or ANP. In all cases, the increase in channel activity coincided with a decrease in channel amplitude, indicating that the membrane potential was approaching equilibrium potential as BK(Ca) was activated. If membrane potential was maintained depolarized with 140 mM KCl in the bathing solution, DBcGMP induced a sustained activation of BK(Ca). In the continued presence of DBcGMP, BK(Ca) was further activated when 100 nM angiotensin II (ANG II) was added to the bathing solution. Experiments were performed to determine the role of BK(Ca) in the regulation by vasorelaxants of mesangial contraction measured as percent maximal and defined by reduction in length induced by replacing 135 mM bath NaCl with KCl. Contraction by ANG II (100 nM = 60.5%) was attenuated by NP (100 μM), ANP (1.0 μM), and DBcGMP (10 μM) in the absence, but not the presence, of iberiotoxin, a specific inhibitor of BK(Ca). These results indicate that guanylyl cyclase-stimulating vasorelaxants counteract ANG II-induced contraction of MC, in part, by repolarizing the membrane through activation of BK(Ca) channels.
KW - angiotensin II
KW - atrial natriuretic peptide
KW - charybdotoxin
KW - guanosine 3',5'-cyclic monophosphate
KW - guanylyl cyclase
KW - iberiotoxin
KW - nitric oxide
UR - http://www.scopus.com/inward/record.url?scp=0029785152&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029785152&partnerID=8YFLogxK
U2 - 10.1152/ajpcell.1996.270.6.c1773
DO - 10.1152/ajpcell.1996.270.6.c1773
M3 - Article
C2 - 8764161
AN - SCOPUS:0029785152
SN - 0363-6143
VL - 270
SP - C1773-C1779
JO - American Journal of Physiology - Cell Physiology
JF - American Journal of Physiology - Cell Physiology
IS - 6 39-6
ER -